1. Home
  2. ALLR vs CAPT Comparison

ALLR vs CAPT Comparison

Compare ALLR & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • CAPT
  • Stock Information
  • Founded
  • ALLR 2004
  • CAPT 2005
  • Country
  • ALLR United States
  • CAPT South Korea
  • Employees
  • ALLR N/A
  • CAPT N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • CAPT Blank Checks
  • Sector
  • ALLR Health Care
  • CAPT Finance
  • Exchange
  • ALLR Nasdaq
  • CAPT Nasdaq
  • Market Cap
  • ALLR 15.8M
  • CAPT 16.0M
  • IPO Year
  • ALLR N/A
  • CAPT N/A
  • Fundamental
  • Price
  • ALLR $1.01
  • CAPT $1.54
  • Analyst Decision
  • ALLR
  • CAPT
  • Analyst Count
  • ALLR 0
  • CAPT 0
  • Target Price
  • ALLR N/A
  • CAPT N/A
  • AVG Volume (30 Days)
  • ALLR 417.1K
  • CAPT 370.9K
  • Earning Date
  • ALLR 08-04-2025
  • CAPT 01-01-0001
  • Dividend Yield
  • ALLR N/A
  • CAPT N/A
  • EPS Growth
  • ALLR N/A
  • CAPT N/A
  • EPS
  • ALLR N/A
  • CAPT N/A
  • Revenue
  • ALLR N/A
  • CAPT $17,389,944.00
  • Revenue This Year
  • ALLR N/A
  • CAPT N/A
  • Revenue Next Year
  • ALLR N/A
  • CAPT N/A
  • P/E Ratio
  • ALLR N/A
  • CAPT N/A
  • Revenue Growth
  • ALLR N/A
  • CAPT 84.70
  • 52 Week Low
  • ALLR $0.61
  • CAPT $0.37
  • 52 Week High
  • ALLR $7.45
  • CAPT $2.88
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 53.22
  • CAPT 71.95
  • Support Level
  • ALLR $0.95
  • CAPT $1.14
  • Resistance Level
  • ALLR $1.08
  • CAPT $1.21
  • Average True Range (ATR)
  • ALLR 0.07
  • CAPT 0.08
  • MACD
  • ALLR 0.01
  • CAPT 0.02
  • Stochastic Oscillator
  • ALLR 59.39
  • CAPT 86.54

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

Share on Social Networks: